Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros

Base de dados
Ano de publicação
Tipo de documento
Assunto da revista
País de afiliação
Intervalo de ano de publicação
1.
Mov Disord ; 2024 Jul 23.
Artigo em Inglês | MEDLINE | ID: mdl-39044616

RESUMO

BACKGROUND: Latin America has played a crucial role in advancing our understanding of Huntington's disease (HD). However, previous global reviews include limited data from Latin America. It is possible that English-based medical search engines may not capture all the relevant studies. METHODS: We searched databases in Spanish, Portuguese, and English. The names of every country in Latin America in English-based search engines were used to ensure we found any study that had molecular ascertainment and provided general epidemiological information or subpopulation data. Additionally, we contacted experts across the region. RESULTS: The search strategy yielded 791 citations; 24 studies met inclusion criteria, representing 12 of 36 countries. The overall pooled prevalence was 0.64 per 100,000 (prediction interval, 0.06-7.22); for cluster regions, it was 54 per 100,000 (95% CI, 34.79-84.92); for juvenile HD, it was 8.7% (prediction interval, 5.12-14.35), and 5.9% (prediction interval, 2.72-13.42) for late-onset HD. The prevalence was higher for Mexico, Peru, and Brazil. However, there were no significant differences between Central America and the Caribbean versus South America. CONCLUSION: The prevalence of HD appears to be similar across Latin America. However, we infer that our findings are underestimates, in part because of limited research and underdiagnosis of HD because of limited access to molecular testing and the availability of neurologists and movement disorders specialists. Future research should focus on identifying pathways to improve access to molecular testing and education and understanding differences among different ancestral groups in Latin America. © 2024 International Parkinson and Movement Disorder Society.

2.
Acta Trop ; 252: 107152, 2024 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-38382592

RESUMO

The control of triatomine vectors depends almost exclusively on conventional insecticides. These compounds can, nevertheless, cause negative effects on environmental and human health as well as induce resistance in triatomines. Therefore, we need to look for more sustainable alternatives. Triatoma pallidipennis is one of the main chagasic vectors in Mexico. We evaluated the insecticidal effectiveness of two oils (neem and cinnamon), and two desiccants (potassium salts of fatty acids and diatomaceous earth), on 3rd instar nymphs of T. pallidipennis. The laboratory test involved direct exposure of the treatments to the insects. We found that diatomaceous earths caused 80 % mortality of nymphs after 30 days. Meanwhile, the cumulative mortality for the other treatments did not exceed 50 %. When applied to inert surfaces, the powder formulation of diatomaceous earth demonstrated greater effectiveness than the aqueous suspension. Thus, diatomaceous earth could be a promising alternative for an environmentally friendly control of triatomines.


Assuntos
Doença de Chagas , Inseticidas , Triatoma , Triatominae , Animais , Humanos , Inseticidas/farmacologia , Terra de Diatomáceas/farmacologia , Insetos Vetores , Ninfa
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA